Literature DB >> 49393

Attenuation and immunogenicity of ts mutants of Eastern encephalitis virus for mice.

A Brown, R Vosdingh, E Zebovitz.   

Abstract

Preliminary experiments were intiated to test the attenuation for mice of chemically induced temperature-sensitive (Ets) mutants of a virulents strain of Eastern encephalitis (E) virus, and the potential of such mutants as live virus vaccines for mice. The reversion frequencies of eight mutants to temperature insensitivity were measured and the defects in their biosynthesis at the non-permissive temperature were studied. All eight mutants were less virulent for mice, but the extent of avirulence varied with the mutant and route of injection. The mutants selected as potential vaccines protected mice against subsequent challenge at 10 to 21 days by the virulent virus of strain E. Neutralizing antibody activity was detected in almost all the mutant-infected mice after 10 days, and was found in all infected mice at 21 days. Immunization by two doses of virus induced a very high protection against intracerebral challenge by virus strain E.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49393     DOI: 10.1099/0022-1317-27-1-111

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  A spontaneous temperature sensitive mutant of Japanese encephalitis virus: preliminary characterization.

Authors:  S Halle; E Zebovitz
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  St. Louis encephalitis virus temperature-sensitive mutants. I. Induction, isolation and preliminary characterization.

Authors:  P G Hollingshead; T A Brawner; T P Fleming
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  A hamster-attenuated, temperature-sensitive mutant of Venezuelan encephalitis virus.

Authors:  J N Krieger; W F Scherer; M E Wiebe; B A Pancake; Z P Harsanyi
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation.

Authors:  Jyotsna Pandya; Rodion Gorchakov; Eryu Wang; Grace Leal; Scott C Weaver
Journal:  Vaccine       Date:  2012-01-02       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.